Skip to main content
Clinical Trials/IRCT201112178428N1
IRCT201112178428N1
Completed
Phase 3

A comparison of the effectiveness, side effects and acceptability of Plavix and Osivix as anti platelet tablets in patients undergoing Coronary artery by pass.

Research Deputy of Hamadan University of Medical Sciences0 sites80 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Research Deputy of Hamadan University of Medical Sciences
Enrollment
80
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Research Deputy of Hamadan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • All patients undergoing open heart surgery
  • Exclusion criteria: 1\- Patients with a prior events of acute coronary syndrome, 2\- Hepatic insufficiency, 3\- History of significant bleeding disorder,4\- Those already taking anti\-platelet and/or anticoagulant therapy, 5\- Age less than 20 and over than 75\.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials